Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is an anticholinergic agent. It is a quaternary ammonium compound that acts as a non-selective muscarinic antagonist.
## Primary Indications
* Management of peptic ulcer disease (historically, now largely replaced by PPIs and H2 blockers).
* Gastrointestinal (GI) spasms.
* Urinary incontinence.
* Parkinsonism symptoms (tremor, rigidity).
## Adult Dosing
* **Peptic Ulcer Disease:** 10-20 mg orally every 3-4 hours as needed, or 50 mg orally every 4-6 hours. Maximum dose typically not exceeding 200 mg daily.
* **GI Spasms:** 10-20 mg orally every 3-4 hours.
* **Urinary Incontinence:** 20 mg orally 3 times daily.
* **Parkinsonism:** 25 mg orally 1-3 times daily.
*Note: Specific dosing may vary based on individual patient response and local protocols. This medication is less commonly used now due to the availability of more effective and targeted therapies.*
## Pediatric Dosing
Dosing in pediatric populations is not well-established and should be approached with extreme caution, if at all, due to potential for adverse effects. Consultation with a pediatric specialist is recommended.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are typically outlined, but caution is advised as elimination may be reduced.
* **Hepatic Impairment:** No specific dose adjustments are typically outlined, but caution is advised.
* **Elderly:** May be more sensitive to anticholinergic effects; lower doses may be necessary.
## Contraindications
* Glaucoma (especially narrow-angle glaucoma).
* Myasthenia gravis.
* Obstructive uropathy (e.g., bladder neck obstruction).
* Gastrointestinal obstruction or ileus.
* Uncontrolled ulcerative colitis.
* Toxic megacolon.
* Tachyarrhythmias.
* Hypersensitivity to walethmade bromide or other anticholinergics.
## Adverse Effects
Common adverse effects are typical of anticholinergics and include dry mouth, blurred vision, constipation, urinary retention, drowsiness, dizziness, confusion, and tachycardia. Less common but serious effects include anhidrosis (decreased sweating) leading to heatstroke, hallucinations, and exacerbation of glaucoma.
## Key Drug Interactions
* **Other Anticholinergic Agents:** Additive effects, increasing the risk of anticholinergic toxicity.
* **Central Nervous System (CNS) Depressants:** May potentiate CNS depressant effects (e.g., sedatives, alcohol, opioids).
* **Potassium Chloride:** Risk of GI ulceration, perforation, and bleeding, especially with slow-release formulations.
* **Antacids/Adsorbents:** May decrease the absorption of walethmade bromide if administered concurrently; separate administration by at least 1-2 hours.
* **Dopaminergic Agents (e.g., Levodopa):** May decrease the absorption and efficacy of levodopa.
## Monitoring
* Monitor for signs and symptoms of anticholinergic side effects (dry mouth, constipation, urinary retention, blurred vision, confusion, drowsiness).
* Assess effectiveness for the specific indication.
* For patients with glaucoma, monitor intraocular pressure if feasible.
* Monitor bowel function.
## Clinical Pearls
* Due to its anticholinergic properties, walethmade bromide can cause the "dry as a bone, blind as a bat, mad as a hatter, red as a beet, hot as a hare" syndrome.
* Use with caution in the elderly due to increased susceptibility to cognitive impairment and other anticholinergic effects.
* Advise patients to avoid operating heavy machinery or engaging in hazardous activities until they know how the medication affects them.
* Ensure adequate hydration and advise patients about the risk of heatstroke due to decreased sweating.
* Consider alternative therapies, especially for peptic ulcer disease, due to improved safety and efficacy profiles of newer agents.
***
**Disclaimer:** This information is intended for clinical use and does not replace comprehensive drug information resources. Always consult the most current prescribing information and relevant clinical guidelines before making therapeutic decisions.
